104 related articles for article (PubMed ID: 16969072)
1. Important differences between topoisomerase-I and -II targeting agents.
Banerji S; Los M
Cancer Biol Ther; 2006 Aug; 5(8):965-6. PubMed ID: 16969072
[No Abstract] [Full Text] [Related]
2. Activation of ATM and histone H2AX phosphorylation induced by mitoxantrone but not by topotecan is prevented by the antioxidant N-acetyl-L-cysteine.
Huang X; Kurose A; Tanaka T; Traganos F; Dai W; Darzynkiewicz Z
Cancer Biol Ther; 2006 Aug; 5(8):959-64. PubMed ID: 16760673
[TBL] [Abstract][Full Text] [Related]
3. Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis.
Kurose A; Tanaka T; Huang X; Halicka HD; Traganos F; Dai W; Darzynkiewicz Z
Cytometry A; 2005 Nov; 68(1):1-9. PubMed ID: 16184611
[TBL] [Abstract][Full Text] [Related]
4. ATM activation and histone H2AX phosphorylation as indicators of DNA damage by DNA topoisomerase I inhibitor topotecan and during apoptosis.
Tanaka T; Kurose A; Huang X; Dai W; Darzynkiewicz Z
Cell Prolif; 2006 Feb; 39(1):49-60. PubMed ID: 16426422
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation.
Zhao H; Traganos F; Darzynkiewicz Z
Cell Cycle; 2008 Oct; 7(19):3048-55. PubMed ID: 18802408
[TBL] [Abstract][Full Text] [Related]
6. Induction of ATM activation, histone H2AX phosphorylation and apoptosis by etoposide: relation to cell cycle phase.
Tanaka T; Halicka HD; Traganos F; Seiter K; Darzynkiewicz Z
Cell Cycle; 2007 Feb; 6(3):371-6. PubMed ID: 17297310
[TBL] [Abstract][Full Text] [Related]
7. Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents.
Tanaka T; Huang X; Halicka HD; Zhao H; Traganos F; Albino AP; Dai W; Darzynkiewicz Z
Cytometry A; 2007 Sep; 71(9):648-61. PubMed ID: 17622968
[TBL] [Abstract][Full Text] [Related]
8. 2-deoxy-D-glucose reduces the level of constitutive activation of ATM and phosphorylation of histone H2AX.
Tanaka T; Kurose A; Halicka HD; Traganos F; Darzynkiewicz Z
Cell Cycle; 2006 Apr; 5(8):878-82. PubMed ID: 16628006
[TBL] [Abstract][Full Text] [Related]
9. Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms.
Siu WY; Lau A; Arooz T; Chow JP; Ho HT; Poon RY
Mol Cancer Ther; 2004 May; 3(5):621-32. PubMed ID: 15141020
[TBL] [Abstract][Full Text] [Related]
10. Constitutive histone H2AX phosphorylation and ATM activation, the reporters of DNA damage by endogenous oxidants.
Tanaka T; Halicka HD; Huang X; Traganos F; Darzynkiewicz Z
Cell Cycle; 2006 Sep; 5(17):1940-5. PubMed ID: 16940754
[TBL] [Abstract][Full Text] [Related]
11. CYP1A1 activation of aminoflavone leads to DNA damage in human tumor cell lines.
Pobst LJ; Ames MM
Cancer Chemother Pharmacol; 2006 May; 57(5):569-76. PubMed ID: 16096788
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of constitutive ATM activation and H2AX phosphorylation in human leukemic TK6 cells by their exposure to static magnetic field.
Halicka HD; Darzynkiewicz Z; Teodori L
Cell Cycle; 2009 Oct; 8(19):3238-40. PubMed ID: 19755848
[No Abstract] [Full Text] [Related]
13. Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks.
Golla RM; Li M; Shen Y; Ji M; Yan Y; Fu K; Greiner TC; McKeithan TW; Chan WC
Hematol Oncol; 2012 Dec; 30(4):175-9. PubMed ID: 22170260
[TBL] [Abstract][Full Text] [Related]
14. Ataxia telangiectasia mutated-dependent regulation of topoisomerase II alpha expression and sensitivity to topoisomerase II inhibitor.
Tamaichi H; Sato M; Porter AC; Shimizu T; Mizutani S; Takagi M
Cancer Sci; 2013 Feb; 104(2):178-84. PubMed ID: 23163762
[TBL] [Abstract][Full Text] [Related]
15. Effects of hydroxyurea and aphidicolin on phosphorylation of ataxia telangiectasia mutated on Ser 1981 and histone H2AX on Ser 139 in relation to cell cycle phase and induction of apoptosis.
Kurose A; Tanaka T; Huang X; Traganos F; Dai W; Darzynkiewicz Z
Cytometry A; 2006 Apr; 69(4):212-21. PubMed ID: 16528719
[TBL] [Abstract][Full Text] [Related]
16. DNA damage response as a biomarker in treatment of leukemias.
Halicka HD; Ozkaynak MF; Levendoglu-Tugal O; Sandoval C; Seiter K; Kajstura M; Traganos F; Jayabose S; Darzynkiewicz Z
Cell Cycle; 2009 Jun; 8(11):1720-4. PubMed ID: 19411853
[TBL] [Abstract][Full Text] [Related]
17. N-acetylcysteine potentiates doxorubicin-induced ATM and p53 activation in ovarian cancer cells.
Brum G; Carbone T; Still E; Correia V; Szulak K; Calianese D; Best C; Cammarata G; Higgins K; Ji F; Di W; Wan Y
Int J Oncol; 2013 Jan; 42(1):211-8. PubMed ID: 23128467
[TBL] [Abstract][Full Text] [Related]
18. Grape seed extract induces anoikis and caspase-mediated apoptosis in human prostate carcinoma LNCaP cells: possible role of ataxia telangiectasia mutated-p53 activation.
Kaur M; Agarwal R; Agarwal C
Mol Cancer Ther; 2006 May; 5(5):1265-74. PubMed ID: 16731759
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid resensitizes cisplatin-resistant ovarian cancer cells.
Lin CT; Lai HC; Lee HY; Lin WH; Chang CC; Chu TY; Lin YW; Lee KD; Yu MH
Cancer Sci; 2008 Jun; 99(6):1218-26. PubMed ID: 18429963
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylated H2Ax is not an unambiguous marker for DNA double-strand breaks.
Cleaver JE; Feeney L; Revet I
Cell Cycle; 2011 Oct; 10(19):3223-4. PubMed ID: 21921674
[No Abstract] [Full Text] [Related]
[Next] [New Search]
